Cited by 5,850Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Open access

Ridker, Paul M., Hennekens, Charles H., Buring, Julie E., Rifai, Nader·2000·New England Journal of Medicine

DOI 10.1056/nejm200003233421202

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. METHODS: We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and a variety of lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. RESULTS: Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), LDL cholesterol (2.4), apolipoprotein B-100 (3.4), HDL cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P<0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). CONCLUSIONS: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm200003233421202

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citation
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Self-citation
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511

Show all 30 references

Research works printed but not linked: 1

Buring JE, 1992, J Myocard Ischemia, 4, 27

Sorted by citations

Items 401–500 of 1,069

The metabolic syndrome and inflammation: association or causation?
Esposito, K., & Giugliano, D. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80048-6 · Cited by 264
Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults
Chun, O. K., Chung, S.-J., Claycombe, K. J., & Song, W. O. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.4.753 · Cited by 263
Beyond lipid lowering: the role of statins in vascular protection
Liao, J. K. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00195-x · Cited by 263
Endothelial function, inflammation, and prognosis in cardiovascular disease
Gonzalez, M. A., & Selwyn, A. P. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.016 · Cited by 263
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events
Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2006) · Circulation · doi:10.1161/circulationaha.106.660043 · Cited by 262
Self-citation
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Obesity and Preeclampsia
Wolf, M. S., Kettyle, E., Sandler, L., Ecker, J. L., Roberts, J., & Thadhani, R. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01551-4 · Cited by 262
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Diamanti‐Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N. L., Kreatsas, G., & Panidis, D. (2006) · Human Reproduction · doi:10.1093/humrep/del003 · Cited by 262
Inflammatory Markers of Coronary Risk
Rader, D. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431609 · Cited by 262
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
Brown, D. A., Breit, S. N., Buring, J. E., Fairlie, W. D., Bauskin, A. R., Liu, T., & Ridker, P. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09093-1 · Cited by 261
Self-citation
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260
Self-citation
Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice
Elahi, M. M., Cagampang, F. R. A., Mukhtar, D., Anthony, F. W., Ohri, S. K., & Hanson, M. A. (2009) · British Journal Of Nutrition · doi:10.1017/s000711450820749x · Cited by 259
Exercise training is not associated with improved levels of C-reactive protein or adiponectin
MARCELL, T. J., McAuley, K. A., Traustadóttir, T., & Reaven, P. D. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.008 · Cited by 259
Epicardial adipose tissue: far more than a fat depot.
Talman, A. H., Psaltis, P. J., Cameron, J. D., Meredith, I. T., SENEVIRATNE, S. K., & Wong, D. T. L. (2014) · PubMed · doi:10.3978/j.issn.2223-3652.2014.11.05 · Cited by 259
Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention
Chew, D. P., Bhatt, D. L., Robbins, M. A., Penn, M. S., Schneider, J. P., Lauer, M. S., Topol, E. J., & Ellis, S. G. (2001) · Circulation · doi:10.1161/hc3401.095074 · Cited by 258
Local Neuroinflammation and the Progression of Alzheimer's Disease
McGeer, P. L., & McGeer, E. G. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100969 · Cited by 257
Cardiac biomarkers and the case for point-of-care testing
McDonnell, B., Hearty, S., Leonard, P., & O’Kennedy, R. J. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.01.019 · Cited by 257
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
Ioannidis, J. P. A. (2011) · JAMA · doi:10.1001/jama.2011.713 · Cited by 256
C-Reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study)
Albert, M. A., Glynn, R. J., Buring, J. E., & Ridker, P. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.067 · Cited by 256
Self-citation
C-reactive protein and cardiovascular disease: new insights from an old molecule
Hirschfield, G. M., & Pepys, M. B. (2003) · QJM · doi:10.1093/qjmed/hcg134 · Cited by 256
Inflammation, Frailty and Cardiovascular Disease
Soysal, P., Arık, F., Smith, L., Jackson, S. E., & Işık, A. T. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-33330-0_7 · Cited by 256
Statins Exert Endothelial Atheroprotective Effects via the KLF2 Transcription Factor
Parmar, K. M., Nambudiri, V. E., Dai, G., Larman, H. B., Gimbrone, M. A., & García‐Cardeña, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500144200 · Cited by 255
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions
DeBoer, M. D. (2012) · Nutrition · doi:10.1016/j.nut.2012.07.003 · Cited by 255
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke
Cipollone, F. (2004) · JAMA · doi:10.1001/jama.291.18.2221 · Cited by 253
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults
Miller, G. E., Freedland, K. E., Carney, R. M., Stetler, C., & Banks, W. A. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00057-6 · Cited by 252
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
Speer, T., Dimmeler, S., Schunk, S. J., Fliser, D., & Ridker, P. M. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00621-9 · Cited by 251
Self-citation
Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease
Rupprecht, H. J., Blankenberg, S., Bickel, C., Rippin, G., Hafner, G., Prellwitz, W., Schlumberger, W., & Meyer, J. (2001) · Circulation · doi:10.1161/hc2601.091703 · Cited by 251
Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients
Higashi, Y., Goto, C., Jitsuiki, D., Umemura, T., Nishioka, K., Hidaka, T., Takemoto, H., Nakamura, S., Soga, J., Chayama, K., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101535 · Cited by 250
Proinflammatory cytokines and osteoporosis
McLean, R. R. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0023-2 · Cited by 250
Intima media thickness in childhood obesity
Reinehr, T., Kieß, W., de Sousa, G., Stoffel‐Wagner, B., & Wunsch, R. (2005) · Metabolism · doi:10.1016/j.metabol.2005.07.016 · Cited by 249
Do workplace-based mindfulness meditation programs improve physiological indices of stress? A systematic review and meta-analysis
Heckenberg, R. A., Eddy, P. J., Kent, S., & Wright, B. J. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.09.010 · Cited by 249
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein
Vickers, M. A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00534-x · Cited by 249
Inflammation in Children and Adolescents With Neuropsychiatric Disorders: A Systematic Review
Mitchell, R. H. B., & Goldstein, B. I. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.013 · Cited by 247
Cytokines in the Pathogenesis of Atherosclerosis
Young, J. B., Libby, P., & Schönbeck, U. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613256 · Cited by 247
Sleep duration, cardiovascular disease, and proinflammatory biomarkers
Grandner, M., Sands-Lincoln, Pak, & Garland (2013) · Nature and Science of Sleep · doi:10.2147/nss.s31063 · Cited by 246
Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale
Halappanavar, S., van den Brule, S., Nymark, P., Gaté, L., Seidel, C., Valentino, S., Zhernovkov, V., Høgh Danielsen, P., De Vizcaya, A., Wolff, H., et al. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00344-4 · Cited by 246
Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry
Avčin, T., Cimaz, R., Silverman, E. D., Cervera, R., Gattorno, M., Garay, S. M., Berkun, Y., Sztajnbok, F., Silva, C. A., Campos, L. M. A., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1209 · Cited by 246
Physical Activity and High-Sensitivity C-Reactive Protein
Plaisance, E. P., & Grandjean, P. W. (2006) · Sports Medicine · doi:10.2165/00007256-200636050-00006 · Cited by 246
Long-Term Effects of a High-Protein, Low-Carbohydrate Diet on Weight Control and Cardiovascular Risk Markers in Obese Hyperinsulinemic Subjects
Brinkworth, G. D., Noakes, M., Keogh, J. B., Luscombe, N. D., Wittert, G. A., & Clifton, P. M. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802617 · Cited by 245
Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers
Pischon, T., Hankinson, S. E., Hotamisligil, G. S., Rifai, N., & Rimm, E. B. (2003) · Obesity Research · doi:10.1038/oby.2003.145 · Cited by 245
Self-citation
C-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity
Retnakaran, R. R., Hanley, A. J., Raif, N., Connelly, P. W., Sermer, M., & Zinman, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030186 · Cited by 244
In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease
Jenny, N. S., Tracy, R. P., Ogg, M. S., Luong, L. A., Kuller, L. H., Arnold, A. M., Sharrett, A. R., & Humphries, S. E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040224.49362.60 · Cited by 244
Low Circulating Vitamin B 6 Is Associated With Elevation of the Inflammation Marker C-Reactive Protein Independently of Plasma Homocysteine Levels
Friso, S., Jacques, P. F., Wilson, P. W. F., Rosenberg, I. H., & Selhub, J. (2001) · Circulation · doi:10.1161/01.cir.103.23.2788 · Cited by 243
Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial
Christ‐Crain, M., Meier, C., Guglielmetti, M., Huber, P., Riesen, W., Staub, J.-J., & Müller-Stich, B. P. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00372-6 · Cited by 243
A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events
Akinkuolie, A. O., Buring, J. E., Ridker, P. M., & Mora, S. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001221 · Cited by 243
Self-citation
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
Morin-Papunen, L. C., Rautio, K., Ruokonen, A., Hedberg, P. S. M., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 243
Consequences of and strategies to deal with residual post‐treatment root canal infection
Wu, M., Dummer, P. M. H., & Wesselink, P. R. (2006) · International Endodontic Journal · doi:10.1111/j.1365-2591.2006.01092.x · Cited by 243
Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque
Janoudi, A., Shamoun, F. E., Kalavakunta, J. K., & Abela, G. S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv653 · Cited by 243
Vascular aspects of multiple sclerosis
D'haeseleer, M., Cambron, M., Vanopdenbosch, L., & De Keyser, J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70105-3 · Cited by 241
PREMATURE ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Bruce, I. N., Gladman, D. D., & Urowitz, M. B. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70138-1 · Cited by 240
Lupus Atherosclerosis Prevention Study (LAPS)
Petri, M. A., Kiani, A. N., Post, W. S., Christopher‐Stine, L., & Magder, L. S. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.136762 · Cited by 240
Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors
Roberts, C. K., Won, D., Pruthi, S., Kurtovic, S., Sindhu, R. K., Vaziri, N. D., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01292.2005 · Cited by 240
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome
James, S. K., Armstrong, P. W., Barnathan, E. S., Califf, R. M., Lindahl, B., Siegbahn, A., Simoons, M. L., Topol, E. J., Venge, P., & Wallentin, L. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02969-8 · Cited by 239
Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors
Saito, M., Ishimitsu, T., Minami, J., Ono, H., Ohrui, M., & Matsuoka, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00380-5 · Cited by 239
Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke
Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · Circulation · doi:10.1161/circulationaha.106.635029 · Cited by 238
Correlation between cardiovascular disease and diabetes mellitus: current concepts
Nesto, R. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.016 · Cited by 238
Can Apical Periodontitis Modify Systemic Levels of Inflammatory Markers? A Systematic Review and Meta-analysis
Gomes, M. S., Blattner, T. C., Filho, M. S., Grecca, F. S., Hugo, F. N., FOUAD, A. F., & Reynolds, M. A. (2013) · Journal of Endodontics · doi:10.1016/j.joen.2013.06.014 · Cited by 238
Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment
Ledue, T. B., & Rifai, N. (2003) · Clinical Chemistry · doi:10.1373/49.8.1258 · Cited by 238
Self-citation
Number of Teeth as a Predictor of Cardiovascular Mortality in a Cohort of 7,674 Subjects Followed for 12 Years
Holmlund, A., Holm, G., & Lind, L. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.090680 · Cited by 237
Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers
Kenny, L. C., Black, M. A., Poston, L., Taylor, R. S., Myers, J., Baker, P. N., McCowan, L. M. E., Simpson, N., Dekker, G., Roberts, C. T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03578 · Cited by 237
Association of C-reactive protein with markers of prevalent atherosclerotic disease
Folsom, A. R., Pankow, J. S., Tracy, R. P., Arnett, D. K., Peacock, J. M., Hong, Y., Djoussé, L., & Eckfeldt, J. H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01603-4 · Cited by 237
C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study
Wilson, P. W. F., Nam, B., Pencina, M. J., D’Agostino, R. B., Benjamin, E. J., & O’Donnell, C. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2473 · Cited by 236
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
Chait, A., Han, C. Y., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400017-jlr200 · Cited by 236
Sex differences in the relation of body composition to markers of inflammation
Thorand, B., Baumert, J., Döring, A., Herder, C., Kolb, H., Rathmann, W., Giani, G., & Köenig, W. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.011 · Cited by 236
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Zaman, S. J., Wasfy, J. H., Kapil, V., Ziaeian, B., Parsonage, W. A., Sriswasdi, S., Chico, T., Capodanno, D., Colleran, R., Sutton, N. R., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00055-8 · Cited by 236
Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study
Wang, T. J., Nam, B., Wilson, P. W. F., Wolf, P. A., Levy, D. A., Polak, J. F., D’Agostino, R. B., & O’Donnell, C. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000034543.78801.69 · Cited by 236
Inflammation and nutritional science for programs/policies and interpretation of research evidence (INSPIRE)
Raiten, D. J., Ashour, F. A. S., Ross, A. C., Meydani, S. N., Dawson, H. D., Stephensen, C. B., Brabin, B. J., Suchdev, P. S., & van Ommen, B. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.194571 · Cited by 234
Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)
Herrington, D. M., Vittinghoff, E., Lin, F., Fong, J., Harris, F., Hunninghake, D. B., Bittner, V., Schrott, H. G., Blumenthal, R. S., & Levy, R. (2002) · Circulation · doi:10.1161/01.cir.0000019406.74017.b2 · Cited by 234
The Role of Oxidative Stress and Inflammation in Cardiovascular Aging
Wu, J., Xia, S., Kalionis, B., Wan, W., & Sun, T. (2014) · BioMed Research International · doi:10.1155/2014/615312 · Cited by 233
The metabolic syndrome and cardiovascular disease
Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 233
Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.047 · Cited by 232
C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality
Tuomisto, K., Jousilahti, P., Sundvall, J., Pajunen, P., & Salomaa, V. V. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-08-0571 · Cited by 232
Prospective Study of Major Dietary Patterns and Stroke Risk in Women
Fung, T. T., Stampfer, M. J., Manson, J. E., Rexrode, K. M., Willett, W. C., & Hu, F. B. (2004) · Stroke · doi:10.1161/01.str.0000135762.89154.92 · Cited by 232
Coffee Drinking and Mortality in 10 European Countries
Gunter, M. J., Murphy, N., Cross, A. J., Dossus, L., Dartois, L., Fagherazzi, G., Kaaks, R., Kuhn, T. E., Boeing, H., Aleksandrova, K., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2945 · Cited by 232
Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study
Sierksma, A., van der Gaag, M., Kluft, C., & Hendriks, H. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601459 · Cited by 231
Relationship of Destructive Periodontal Disease to the Acute‐Phase Response
Craig, R. G., Yip, J., So, M. K., Boylan, R. J., Socransky, S. S., & Haffajee, A. D. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.7.1007 · Cited by 230
C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases
Li, J., & Fang, C. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.014 · Cited by 230
Effects of intranasal 17β-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women
Rachoń, D., Suchecka-Rachoń, K., Hak, Ł., & Myśliwska, J. M. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000227400.60816.52 · Cited by 230
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4773 · Cited by 229
C-reactive Protein is Associated With Sleep Disordered Breathing Independent of Adiposity
Punjabi, N. M., & Beamer, B. A. (2007) · SLEEP · doi:10.1093/sleep/30.1.29 · Cited by 228
Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women
Krebs, J. D., Browning, L. M., McLean, N., Rothwell, J. L., Mishra, G. D., Moore, C. S., & Jebb, S. A. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803309 · Cited by 228
A conceptual model for understanding the rapid COVID-19–related increase in food insecurity and its impact on health and healthcare
Leddy, A. M., Weiser, S. D., Palar, K., & Seligman, H. K. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa226 · Cited by 228
Relationships of mitral annular calcification to cardiovascular risk factors: The Multi-Ethnic Study of Atherosclerosis (MESA)
Kanjanauthai, S., Nasir, K., Katz, R., Rivera, J. J., Takasu, J., Blumenthal, R. S., Eng, J., & Budoff, M. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.072 · Cited by 227
Vascular Oxidant Stress and Inflammation in Hyperhomocysteinemia
Papatheodorou, L., & Weiss, N. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1750 · Cited by 227
Sex differences in inflammatory markers: what is the contribution of visceral adiposity?
Cartier, A., Côté, M., Lemieux, I., Përusse, L., Tremblay, A., Bouchard, C., & Després, J. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27030 · Cited by 227
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
Schett, G. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2495 · Cited by 227
The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays
Zhan, L., Guo, S., Song, F., Gong, Y. M., Xu, F., Boulware, D. R., McAlpine, M. C., Chan, W. C. W., & Bischof, J. C. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02302 · Cited by 227
C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study
Folsom, A. R., Aleksic, N., Catellier, D., Juneja, H. S., & Wu, K. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124054 · Cited by 227
Cardiovascular risk factors in women with and without rheumatoid arthritis
Solomon, D. H., Curhan, G. C., Rimm, E. B., Cannuscio, C. C., & Karlson, E. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20636 · Cited by 226
Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout
Crittenden, D. B., Lehmann, R. A., SCHNECK, L., Keenan, R. T., Shah, B., Greenberg, J. D., Cronstein, B. N., Sedlis, S. P., & Pillinger, M. H. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111533 · Cited by 226
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
Huizinga, T. W. J., Fleischmann, R., Jasson, M., Radin, A. R., van Adelsberg, J., Fiore, S., Huang, X., Yancopoulos, G. D., Stahl, N., & Genovese, M. C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204405 · Cited by 226
High sensitivity C-reactive protein in asthma
Takemura, M., Matsumoto, H., Niimi, A., Ueda, T., Matsuoka, H., Yamaguchi, M., Jinnai, M., Muro, S., Hirai, T., Ito, Y., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00114405 · Cited by 226
Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men
Pradhan, A. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000025636.03561.ee · Cited by 226
Self-citation
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
Rho, Y. H., Chung, C. P., Oeser, A. M., Solus, J. F., Asanuma, Y., Sokka, T., Pincus, T., Raggi, P., Gebretsadik, T. S., Shintani, A., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.25009 · Cited by 225
C-reactive protein in atherosclerosis: A causal factor?
Paffen, E., & de Maat, M. P. M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.004 · Cited by 225
Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events
Boekholdt, S. M., Agema, W. R. P., Peters, R. J. G., Zwinderman, A. H., van der Wall, E. E., Reitsma, P. H., Kastelein, J. J. P., & Jukema, J. W. (2003) · Circulation · doi:10.1161/01.cir.0000068311.40161.28 · Cited by 224
Inflammation as a Possible Link Between Coronary and Carotid Plaque Instability
Lombardo, A., Biasucci, L. M., Lanza, G. A., Coli, S., Silvestri, P., Cianflone, D., Liuzzo, G., Burzotta, F., Crea, F., & Maseri, A. (2004) · Circulation · doi:10.1161/01.cir.0000130786.28008.56 · Cited by 222
Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial
de Jager, J., Kooy, A., Lehert, P., Bets, D., Wulffelé, M. G., Teerlink, T., Scheffer, P. G., Schalkwijk, C., Donker, A. J. M., & Stehouwer, C. D. A. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01420.x · Cited by 222
Why Is Protein–Energy Wasting Associated With Mortality in Chronic Kidney Disease?
Kovesdy, C. P., & Kalantar‐Zadeh, K. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2008.10.002 · Cited by 221
High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes Mellitus
Pfützner, A., & Forst, T. M. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.28 · Cited by 221

Authors: Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N.
Affiliations: Brigham and Women's Hospital (US)
Boston Children's Hospital (US)
ORCID: Ridker, Paul M.
Hennekens, Charles H.
Buring, Julie E.
Rifai, Nader
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-03-23
Volume: 342
Issue: 12
Pages: 836-843
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200003233421202
OpenAlex: W2058610272
Cited by: 5,850
References: 30
Citations by year: 2026: 97 · 2025: 120 · 2024: 113 · 2023: 125 · 2022: 148 · 2021: 143 · 2020: 165 · 2019: 140 · 2018: 167 · 2017: 131 · 2016: 169 · 2015: 199 · 2014: 223 · 2013: 234 · 2012: 258
FWCI: 286.27
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University Libraries (University of Maryland) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park)
Funders: National Institutes of Health (5r01hl043851-10)
National Heart, Lung, and Blood Institute (R01HL058755, HL43851, HL-58755)
National Cancer Institute (CA-47988, R01CA047988)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: C-reactive protein, inflammatory markers, cardiovascular risk prediction, postmenopausal women, serum amyloid A, interleukin-6, sICAM-1, homocysteine, apolipoprotein B-100, LDL cholesterol, coronary artery disease, myocardial infarction, stroke, coronary revascularization, risk prediction model
MeSH terms: Serum Amyloid A Protein, Analysis of Variance, Apolipoproteins, C-Reactive Protein, Cardiovascular Diseases, Female, Homocysteine, Humans, Lipids, Middle Aged, Prospective Studies, Protein Precursors, Risk, Biomarkers, Interleukin-6, Case-Control Studies, Intercellular Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks